Gastroenterology
Volume 128, Issue 7 , Pages 1787-1795, June 2005

Positron Emission Tomography Imaging of Adenoviral-Mediated Transgene Expression in Liver Cancer Patients

  • Iván Peñuelas

      Affiliations

    • Department of Nuclear Medicine, Clínica Universitaria de Navarra, Pamplona, Spain
    • MicroPET Research Unit, Clínica Universitaria de Navarra-Centro de Investigación Médica Aplicada, Pamplona, Spain
    • I.P. and G.M. contributed equally to this work.
    • Corresponding Author InformationAddress requests for reprints to: Iván Peñuelas, PhD, Department of Nuclear Medicine, Clínica Universitaria de Navarra, Universidad de Navarra, Av Pío XII 36, 31008 Pamplona, Spain. fax: (34) 948-296-500.
  • ,
  • Guillermo Mazzolini

      Affiliations

    • Liver Unit, Clínica Universitaria de Navarra, Pamplona, Spain
    • Division of Hepatology and Gene Therapy, School of Medicine, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Spain
    • I.P. and G.M. contributed equally to this work.
  • ,
  • José F. Boán

      Affiliations

    • Department of Nuclear Medicine, Clínica Universitaria de Navarra, Pamplona, Spain
  • ,
  • Bruno Sangro

      Affiliations

    • Liver Unit, Clínica Universitaria de Navarra, Pamplona, Spain
  • ,
  • Josep Martí-Climent

      Affiliations

    • MicroPET Research Unit, Clínica Universitaria de Navarra-Centro de Investigación Médica Aplicada, Pamplona, Spain
  • ,
  • María Ruiz

      Affiliations

    • Department of Nuclear Medicine, Clínica Universitaria de Navarra, Pamplona, Spain
    • Liver Unit, Clínica Universitaria de Navarra, Pamplona, Spain
  • ,
  • Juan Ruiz

      Affiliations

    • Department of Nuclear Medicine, Clínica Universitaria de Navarra, Pamplona, Spain
    • Liver Unit, Clínica Universitaria de Navarra, Pamplona, Spain
  • ,
  • Nagichettiar Satyamurthy

      Affiliations

    • Department of Molecular and Medical Pharmacology, University of California-Los Angeles School of Medicine, Los Angeles, California
  • ,
  • Cheng Qian

      Affiliations

    • Division of Hepatology and Gene Therapy, School of Medicine, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Spain
  • ,
  • Jorge R. Barrio

      Affiliations

    • Department of Molecular and Medical Pharmacology, University of California-Los Angeles School of Medicine, Los Angeles, California
  • ,
  • Michael E. Phelps

      Affiliations

    • Department of Molecular and Medical Pharmacology, University of California-Los Angeles School of Medicine, Los Angeles, California
  • ,
  • José A. Richter

      Affiliations

    • Department of Nuclear Medicine, Clínica Universitaria de Navarra, Pamplona, Spain
  • ,
  • Sanjiv S. Gambhir

      Affiliations

    • Department of Radiology and the Bio-X Program, Molecular Imaging Program at Stanford (MIPS), Stanford University School of Medicine, Stanford, California
  • ,
  • Jesús Prieto

      Affiliations

    • Liver Unit, Clínica Universitaria de Navarra, Pamplona, Spain
    • Division of Hepatology and Gene Therapy, School of Medicine, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Spain

Received 22 October 2004; accepted 9 February 2005.

Background & Aims: In gene-therapy protocols, imaging of gene expression is needed to evaluate the transduction efficiency of the vector, its tissue distribution, and the duration of transgene expression and to assess the feasibility of repeated vector administration. Methods: We have used positron emission tomography with a fluorine-18-labeled penciclovir analogue to monitor thymidine kinase gene expression after intratumoral injection of a first-generation recombinant adenovirus in patients with hepatocellular carcinoma. Patients were enrolled in a pilot clinical trial and treated with escalating doses of the vector. Two days after adenovirus inoculation, transgene expression was evaluated during the first hours after administration of the radiotracer both on the treated lesion and on a whole-body basis. Results: Transgene expression in the tumor was dependent on the injected dose of the adenovirus and was detectable in all patients who received ≥1012 viral particles. However, when the study was repeated 9 days after vector injection, no expression could be observed. It is interesting to note that no specific expression of the transgene could be detected in distant organs or in the surrounding cirrhotic tissue in any of the cases studied. Conclusions: Our findings show the real possibility of imaging transgene expression in humans by using viral vectors. We show that hepatocarcinoma is a permissive tumor for adenoviral infection and that the nontumoral cirrhotic liver is spared from transduction when the vector is administered by intratumoral injection. These results show that positron emission tomography imaging may help in the design of gene-therapy strategies and in the clinical assessment of new-generation vectors.

Abbreviations used in this paper:  CT, computerized tomography , [18F]FHBG, [18F]9-(4-[18F]-fluoro-3-hydroxymethylbutyl)-guanine , [124I]FIAU, 5-[124I]iodo-2′-fluoro-2′-deoxy-1-β-d-arabinofuranosyl-5-iodouracil , HCC, hepatocellular carcinoma , HSV1-tk, herpes simplex virus thymidine kinase , PET, positron emission tomography , SUV, standard uptake value , vp, viral particle

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by grants PI-24/2002-01 (I.P.) and 2003–04 (G.M.) from Departamento de Educación, Gobierno de Navarra, and PI 031253 (G.M.) from Fondo de Investigaciones Sanitarias. The work was also supported with funds from Plan de Investigación de la Universidad de Navarra, Centro de Investigación Médica Aplicada Project, Red Temática de Investigación Cooperativa de Centros de Cáncer (C03-10), and Red Nacional de Investigación en Hepatología y Gastroenterología (C03-02). S.S.G. is supported by the US National Institutes of Health and the Department of Energy.

PII: S0016-5085(05)00441-5

doi:10.1053/j.gastro.2005.03.024

Gastroenterology
Volume 128, Issue 7 , Pages 1787-1795, June 2005